マイクロRNA（miRNA）の世界市場 2020年：企業別、地域別、種類・用途別

• 英文タイトル：Global MicroRNA (miRNA) Market 2020 by Company, Regions, Type and Application, Forecast to 2025

• レポートコード：D005-00662 • 出版社/出版日：GlobalInfoResearch / 2020年5月29日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、101ページ • 納品方法：Eメール • 産業分類：医療・製薬

• 販売価格（消費税別）

Single User	￥515,040 (USD3,480)	▷ お問い合わせ
Multi User	￥772,560 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,030,080 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

本調査レポートでは、マイクロRNA（miRNA）の世界市場を広く調査・分析し、今後の市場展望をまとめております。マイクロRNA（miRNA）の種類別市場規模（サンプル収集、miRNA cDNA合成、プロファイリングおよび精製、検出、機能研究）、用途別市場規模（がん、感染症、免疫疾患、心血管疾患、神経疾患、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Thermofisher Scientific (Life Technologies)、GeneCopoeia, Inc.、QIAGEN (Exiqon)、Agilent Technologies、Synlogic、Merck KGaA、Quantabio、Dharmacon (Horizon Discovery Group)、NanoString Technologies, Inc.、New England Biolabs、NanoString Technologies, Inc.、BioGenex、SeqMatic LLC ・地域別グローバル市場分析 2015年-2020年 ・マイクロRNA（miRNA）の北米市場（アメリカ、カナダ、メキシコ） ・マイクロRNA（miRNA）のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・マイクロRNA（miRNA）のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・マイクロRNA（miRNA）の南米市場（ブラジル、アルゼンチン） ・マイクロRNA（miRNA）の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：サンプル収集、miRNA cDNA合成、プロファイリングおよび精製、検出、機能研究 ・用途別分析：がん、感染症、免疫疾患、心血管疾患、神経疾患、その他 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論

Market Overview
The global MicroRNA (miRNA) market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 10.1% in the forecast period of 2020 to 2025 and will expected to reach USD 257.1 million by 2025, from USD 175 million in 2019.

The MicroRNA (miRNA) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
MicroRNA (miRNA) market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, MicroRNA (miRNA) market has been segmented into:
Sample collection
miRNA cDNA Synthesis
Profiling & Purification
Detection
Functional Studies

By Application, MicroRNA (miRNA) has been segmented into:
Cancer
Infectious Diseases
Immunological Disorder
Cardiovascular Disease
Neurological Disease
Others

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global MicroRNA (miRNA) market presented in the report. This section sheds light on the sales growth of different regional and country-level MicroRNA (miRNA) markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global MicroRNA (miRNA) market.

The report offers in-depth assessment of the growth and other aspects of the MicroRNA (miRNA) market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and MicroRNA (miRNA) Market Share Analysis
MicroRNA (miRNA) competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, MicroRNA (miRNA) sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the MicroRNA (miRNA) sales, revenue and market share for each player covered in this report.

The major players covered in MicroRNA (miRNA) are:
Thermofisher Scientific (Life Technologies)
GeneCopoeia, Inc.
QIAGEN (Exiqon)
Agilent Technologies
Synlogic
Merck KGaA
Quantabio
Dharmacon (Horizon Discovery Group)
NanoString Technologies, Inc.
New England Biolabs
NanoString Technologies, Inc.
BioGenex
SeqMatic LLC

レポート目次

---

Table of Contents

1 MicroRNA (miRNA) Market Overview
1.1 Product Overview and Scope of MicroRNA (miRNA)
1.2 Classification of MicroRNA (miRNA) by Type
1.2.1 Global MicroRNA (miRNA) Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global MicroRNA (miRNA) Revenue Market Share by Type in 2019
1.2.3 Sample collection
1.2.4 miRNA cDNA Synthesis
1.2.5 Profiling & Purification
1.2.6 Detection
1.2.7 Functional Studies
1.3 Global MicroRNA (miRNA) Market by Application
1.3.1 Overview: Global MicroRNA (miRNA) Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Cancer
1.3.3 Infectious Diseases
1.3.4 Immunological Disorder
1.3.5 Cardiovascular Disease
1.3.6 Neurological Disease
1.3.7 Others
1.4 Global MicroRNA (miRNA) Market by Regions
1.4.1 Global MicroRNA (miRNA) Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of MicroRNA (miRNA) (2015-2025)
1.4.3 North America (USA, Canada and Mexico) MicroRNA (miRNA) Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) MicroRNA (miRNA) Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) MicroRNA (miRNA) Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) MicroRNA (miRNA) Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) MicroRNA (miRNA) Status and Prospect (2015-2025)
2 Company Profiles
2.1 Thermofisher Scientific (Life Technologies)
2.1.1 Thermofisher Scientific (Life Technologies) Details
2.1.2 Thermofisher Scientific (Life Technologies) Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Thermofisher Scientific (Life Technologies) SWOT Analysis
2.1.4 Thermofisher Scientific (Life Technologies) Product and Services
2.1.5 Thermofisher Scientific (Life Technologies) MicroRNA (miRNA) Revenue, Gross Margin and Market Share (2018-2019)
2.2 GeneCopoeia, Inc.
2.2.1 GeneCopoeia, Inc. Details
2.2.2 GeneCopoeia, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 GeneCopoeia, Inc. SWOT Analysis
2.2.4 GeneCopoeia, Inc. Product and Services
2.2.5 GeneCopoeia, Inc. MicroRNA (miRNA) Revenue, Gross Margin and Market Share (2018-2019)
2.3 QIAGEN (Exiqon)
2.3.1 QIAGEN (Exiqon) Details
2.3.2 QIAGEN (Exiqon) Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 QIAGEN (Exiqon) SWOT Analysis
2.3.4 QIAGEN (Exiqon) Product and Services
2.3.5 QIAGEN (Exiqon) MicroRNA (miRNA) Revenue, Gross Margin and Market Share (2018-2019)
2.4 Agilent Technologies
2.4.1 Agilent Technologies Details
2.4.2 Agilent Technologies Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Agilent Technologies SWOT Analysis
2.4.4 Agilent Technologies Product and Services
2.4.5 Agilent Technologies MicroRNA (miRNA) Revenue, Gross Margin and Market Share (2018-2019)
2.5 Synlogic
2.5.1 Synlogic Details
2.5.2 Synlogic Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Synlogic SWOT Analysis
2.5.4 Synlogic Product and Services
2.5.5 Synlogic MicroRNA (miRNA) Revenue, Gross Margin and Market Share (2018-2019)
2.6 Merck KGaA
2.6.1 Merck KGaA Details
2.6.2 Merck KGaA Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Merck KGaA SWOT Analysis
2.6.4 Merck KGaA Product and Services
2.6.5 Merck KGaA MicroRNA (miRNA) Revenue, Gross Margin and Market Share (2018-2019)
2.7 Quantabio
2.7.1 Quantabio Details
2.7.2 Quantabio Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Quantabio SWOT Analysis
2.7.4 Quantabio Product and Services
2.7.5 Quantabio MicroRNA (miRNA) Revenue, Gross Margin and Market Share (2018-2019)
2.8 Dharmacon (Horizon Discovery Group)
2.8.1 Dharmacon (Horizon Discovery Group) Details
2.8.2 Dharmacon (Horizon Discovery Group) Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Dharmacon (Horizon Discovery Group) SWOT Analysis
2.8.4 Dharmacon (Horizon Discovery Group) Product and Services
2.8.5 Dharmacon (Horizon Discovery Group) MicroRNA (miRNA) Revenue, Gross Margin and Market Share (2018-2019)
2.9 NanoString Technologies, Inc.
2.9.1 NanoString Technologies, Inc. Details
2.9.2 NanoString Technologies, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 NanoString Technologies, Inc. SWOT Analysis
2.9.4 NanoString Technologies, Inc. Product and Services
2.9.5 NanoString Technologies, Inc. MicroRNA (miRNA) Revenue, Gross Margin and Market Share (2018-2019)
2.10 New England Biolabs
2.10.1 New England Biolabs Details
2.10.2 New England Biolabs Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 New England Biolabs SWOT Analysis
2.10.4 New England Biolabs Product and Services
2.10.5 New England Biolabs MicroRNA (miRNA) Revenue, Gross Margin and Market Share (2018-2019)
2.11 NanoString Technologies, Inc.
2.11.1 NanoString Technologies, Inc. Details
2.11.2 NanoString Technologies, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 NanoString Technologies, Inc. SWOT Analysis
2.11.4 NanoString Technologies, Inc. Product and Services
2.11.5 NanoString Technologies, Inc. MicroRNA (miRNA) Revenue, Gross Margin and Market Share (2018-2019)
2.12 BioGenex
2.12.1 BioGenex Details
2.12.2 BioGenex Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 BioGenex SWOT Analysis
2.12.4 BioGenex Product and Services
2.12.5 BioGenex MicroRNA (miRNA) Revenue, Gross Margin and Market Share (2018-2019)
2.13 SeqMatic LLC
2.13.1 SeqMatic LLC Details
2.13.2 SeqMatic LLC Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 SeqMatic LLC SWOT Analysis
2.13.4 SeqMatic LLC Product and Services
2.13.5 SeqMatic LLC MicroRNA (miRNA) Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global MicroRNA (miRNA) Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 MicroRNA (miRNA) Players Market Share
3.2.2 Top 10 MicroRNA (miRNA) Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global MicroRNA (miRNA) Revenue and Market Share by Regions
4.2 North America MicroRNA (miRNA) Revenue and Growth Rate (2015-2020)
4.3 Europe MicroRNA (miRNA) Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific MicroRNA (miRNA) Revenue and Growth Rate (2015-2020)
4.5 South America MicroRNA (miRNA) Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa MicroRNA (miRNA) Revenue and Growth Rate (2015-2020)
5 North America MicroRNA (miRNA) Revenue by Countries
5.1 North America MicroRNA (miRNA) Revenue by Countries (2015-2020)
5.2 USA MicroRNA (miRNA) Revenue and Growth Rate (2015-2020)
5.3 Canada MicroRNA (miRNA) Revenue and Growth Rate (2015-2020)
5.4 Mexico MicroRNA (miRNA) Revenue and Growth Rate (2015-2020)
6 Europe MicroRNA (miRNA) Revenue by Countries
6.1 Europe MicroRNA (miRNA) Revenue by Countries (2015-2020)
6.2 Germany MicroRNA (miRNA) Revenue and Growth Rate (2015-2020)
6.3 UK MicroRNA (miRNA) Revenue and Growth Rate (2015-2020)
6.4 France MicroRNA (miRNA) Revenue and Growth Rate (2015-2020)
6.5 Russia MicroRNA (miRNA) Revenue and Growth Rate (2015-2020)
6.6 Italy MicroRNA (miRNA) Revenue and Growth Rate (2015-2020)
7 Asia-Pacific MicroRNA (miRNA) Revenue by Countries
7.1 Asia-Pacific MicroRNA (miRNA) Revenue by Countries (2015-2020)
7.2 China MicroRNA (miRNA) Revenue and Growth Rate (2015-2020)
7.3 Japan MicroRNA (miRNA) Revenue and Growth Rate (2015-2020)
7.4 Korea MicroRNA (miRNA) Revenue and Growth Rate (2015-2020)
7.5 India MicroRNA (miRNA) Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia MicroRNA (miRNA) Revenue and Growth Rate (2015-2020)
8 South America MicroRNA (miRNA) Revenue by Countries
8.1 South America MicroRNA (miRNA) Revenue by Countries (2015-2020)
8.2 Brazil MicroRNA (miRNA) Revenue and Growth Rate (2015-2020)
8.3 Argentina MicroRNA (miRNA) Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue MicroRNA (miRNA) by Countries
9.1 Middle East & Africa MicroRNA (miRNA) Revenue by Countries (2015-2020)
9.2 Saudi Arabia MicroRNA (miRNA) Revenue and Growth Rate (2015-2020)
9.3 UAE MicroRNA (miRNA) Revenue and Growth Rate (2015-2020)
9.4 Egypt MicroRNA (miRNA) Revenue and Growth Rate (2015-2020)
9.5 South Africa MicroRNA (miRNA) Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global MicroRNA (miRNA) Revenue and Market Share by Type (2015-2020)
10.2 Global MicroRNA (miRNA) Market Forecast by Type (2019-2024)
10.3 Sample collection Revenue Growth Rate (2015-2025)
10.4 miRNA cDNA Synthesis Revenue Growth Rate (2015-2025)
10.5 Profiling & Purification Revenue Growth Rate (2015-2025)
10.6 Detection Revenue Growth Rate (2015-2025)
10.7 Functional Studies Revenue Growth Rate (2015-2025)
11 Global MicroRNA (miRNA) Market Segment by Application
11.1 Global MicroRNA (miRNA) Revenue Market Share by Application (2015-2020)
11.2 MicroRNA (miRNA) Market Forecast by Application (2019-2024)
11.3 Cancer Revenue Growth (2015-2020)
11.4 Infectious Diseases Revenue Growth (2015-2020)
11.5 Immunological Disorder Revenue Growth (2015-2020)
11.6 Cardiovascular Disease Revenue Growth (2015-2020)
11.7 Neurological Disease Revenue Growth (2015-2020)
11.8 Others Revenue Growth (2015-2020)
12 Global MicroRNA (miRNA) Market Size Forecast (2021-2025)
12.1 Global MicroRNA (miRNA) Market Size Forecast (2021-2025)
12.2 Global MicroRNA (miRNA) Market Forecast by Regions (2021-2025)
12.3 North America MicroRNA (miRNA) Revenue Market Forecast (2021-2025)
12.4 Europe MicroRNA (miRNA) Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific MicroRNA (miRNA) Revenue Market Forecast (2021-2025)
12.6 South America MicroRNA (miRNA) Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa MicroRNA (miRNA) Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

List of Tables

Table 1. Global MicroRNA (miRNA) Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of MicroRNA (miRNA) by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global MicroRNA (miRNA) Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market MicroRNA (miRNA) Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Thermofisher Scientific (Life Technologies) Corporate Information, Location and Competitors
Table 6. Thermofisher Scientific (Life Technologies) MicroRNA (miRNA) Major Business
Table 7. Thermofisher Scientific (Life Technologies) MicroRNA (miRNA) Total Revenue (USD Million) (2017-2018)
Table 8. Thermofisher Scientific (Life Technologies) SWOT Analysis
Table 9. Thermofisher Scientific (Life Technologies) MicroRNA (miRNA) Product and Solutions
Table 10. Thermofisher Scientific (Life Technologies) MicroRNA (miRNA) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. GeneCopoeia, Inc. Corporate Information, Location and Competitors
Table 12. GeneCopoeia, Inc. MicroRNA (miRNA) Major Business
Table 13. GeneCopoeia, Inc. MicroRNA (miRNA) Total Revenue (USD Million) (2018-2019)
Table 14. GeneCopoeia, Inc. SWOT Analysis
Table 15. GeneCopoeia, Inc. MicroRNA (miRNA) Product and Solutions
Table 16. GeneCopoeia, Inc. MicroRNA (miRNA) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. QIAGEN (Exiqon) Corporate Information, Location and Competitors
Table 18. QIAGEN (Exiqon) MicroRNA (miRNA) Major Business
Table 19. QIAGEN (Exiqon) MicroRNA (miRNA) Total Revenue (USD Million) (2017-2018)
Table 20. QIAGEN (Exiqon) SWOT Analysis
Table 21. QIAGEN (Exiqon) MicroRNA (miRNA) Product and Solutions
Table 22. QIAGEN (Exiqon) MicroRNA (miRNA) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Agilent Technologies Corporate Information, Location and Competitors
Table 24. Agilent Technologies MicroRNA (miRNA) Major Business
Table 25. Agilent Technologies MicroRNA (miRNA) Total Revenue (USD Million) (2017-2018)
Table 26. Agilent Technologies SWOT Analysis
Table 27. Agilent Technologies MicroRNA (miRNA) Product and Solutions
Table 28. Agilent Technologies MicroRNA (miRNA) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Synlogic Corporate Information, Location and Competitors
Table 30. Synlogic MicroRNA (miRNA) Major Business
Table 31. Synlogic MicroRNA (miRNA) Total Revenue (USD Million) (2017-2018)
Table 32. Synlogic SWOT Analysis
Table 33. Synlogic MicroRNA (miRNA) Product and Solutions
Table 34. Synlogic MicroRNA (miRNA) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Merck KGaA Corporate Information, Location and Competitors
Table 36. Merck KGaA MicroRNA (miRNA) Major Business
Table 37. Merck KGaA MicroRNA (miRNA) Total Revenue (USD Million) (2017-2018)
Table 38. Merck KGaA SWOT Analysis
Table 39. Merck KGaA MicroRNA (miRNA) Product and Solutions
Table 40. Merck KGaA MicroRNA (miRNA) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Quantabio Corporate Information, Location and Competitors
Table 42. Quantabio MicroRNA (miRNA) Major Business
Table 43. Quantabio MicroRNA (miRNA) Total Revenue (USD Million) (2017-2018)
Table 44. Quantabio SWOT Analysis
Table 45. Quantabio MicroRNA (miRNA) Product and Solutions
Table 46. Quantabio MicroRNA (miRNA) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Dharmacon (Horizon Discovery Group) Corporate Information, Location and Competitors
Table 48. Dharmacon (Horizon Discovery Group) MicroRNA (miRNA) Major Business
Table 49. Dharmacon (Horizon Discovery Group) MicroRNA (miRNA) Total Revenue (USD Million) (2017-2018)
Table 50. Dharmacon (Horizon Discovery Group) SWOT Analysis
Table 51. Dharmacon (Horizon Discovery Group) MicroRNA (miRNA) Product and Solutions
Table 52. Dharmacon (Horizon Discovery Group) MicroRNA (miRNA) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. NanoString Technologies, Inc. Corporate Information, Location and Competitors
Table 54. NanoString Technologies, Inc. MicroRNA (miRNA) Major Business
Table 55. NanoString Technologies, Inc. MicroRNA (miRNA) Total Revenue (USD Million) (2017-2018)
Table 56. NanoString Technologies, Inc. SWOT Analysis
Table 57. NanoString Technologies, Inc. MicroRNA (miRNA) Product and Solutions
Table 58. NanoString Technologies, Inc. MicroRNA (miRNA) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. New England Biolabs Corporate Information, Location and Competitors
Table 60. New England Biolabs MicroRNA (miRNA) Major Business
Table 61. New England Biolabs MicroRNA (miRNA) Total Revenue (USD Million) (2017-2018)
Table 62. New England Biolabs SWOT Analysis
Table 63. New England Biolabs MicroRNA (miRNA) Product and Solutions
Table 64. New England Biolabs MicroRNA (miRNA) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. NanoString Technologies, Inc. Corporate Information, Location and Competitors
Table 66. NanoString Technologies, Inc. MicroRNA (miRNA) Major Business
Table 67. NanoString Technologies, Inc. MicroRNA (miRNA) Total Revenue (USD Million) (2017-2018)
Table 68. NanoString Technologies, Inc. SWOT Analysis
Table 69. NanoString Technologies, Inc. MicroRNA (miRNA) Product and Solutions
Table 70. NanoString Technologies, Inc. MicroRNA (miRNA) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 71. BioGenex Corporate Information, Location and Competitors
Table 72. BioGenex MicroRNA (miRNA) Major Business
Table 73. BioGenex MicroRNA (miRNA) Total Revenue (USD Million) (2017-2018)
Table 74. BioGenex SWOT Analysis
Table 75. BioGenex MicroRNA (miRNA) Product and Solutions
Table 76. BioGenex MicroRNA (miRNA) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 77. SeqMatic LLC Corporate Information, Location and Competitors
Table 78. SeqMatic LLC MicroRNA (miRNA) Major Business
Table 79. SeqMatic LLC MicroRNA (miRNA) Total Revenue (USD Million) (2017-2018)
Table 80. SeqMatic LLC SWOT Analysis
Table 81. SeqMatic LLC MicroRNA (miRNA) Product and Solutions
Table 82. SeqMatic LLC MicroRNA (miRNA) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 83. Global MicroRNA (miRNA) Revenue (Million USD) by Players (2015-2020)
Table 84. Global MicroRNA (miRNA) Revenue Share by Players (2015-2020)
Table 85. Global MicroRNA (miRNA) Revenue (Million USD) by Regions (2015-2020)
Table 86. Global MicroRNA (miRNA) Revenue Market Share by Regions (2015-2020)
Table 87. North America MicroRNA (miRNA) Revenue by Countries (2015-2020)
Table 88. North America MicroRNA (miRNA) Revenue Market Share by Countries (2015-2020)
Table 89. Europe MicroRNA (miRNA) Revenue (Million USD) by Countries (2015-2020)
Table 90. Asia-Pacific MicroRNA (miRNA) Revenue (Million USD) by Countries (2015-2020)
Table 91. South America MicroRNA (miRNA) Revenue by Countries (2015-2020)
Table 92. South America MicroRNA (miRNA) Revenue Market Share by Countries (2015-2020)
Table 93. Middle East and Africa MicroRNA (miRNA) Revenue (Million USD) by Countries (2015-2020)
Table 94. Middle East and Africa MicroRNA (miRNA) Revenue Market Share by Countries (2015-2020)
Table 95. Global MicroRNA (miRNA) Revenue (Million USD) by Type (2015-2020)
Table 96. Global MicroRNA (miRNA) Revenue Share by Type (2015-2020)
Table 97. Global MicroRNA (miRNA) Revenue Forecast by Type (2021-2025)
Table 98. Global MicroRNA (miRNA) Revenue by Application (2015-2020)
Table 99. Global MicroRNA (miRNA) Revenue Share by Application (2015-2020)
Table 100. Global MicroRNA (miRNA) Revenue Forecast by Application (2021-2025)
Table 101. Global MicroRNA (miRNA) Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. MicroRNA (miRNA) Picture
Figure 2. Global MicroRNA (miRNA) Revenue Market Share by Type in 2019
Figure 3. Sample collection Picture
Figure 4. miRNA cDNA Synthesis Picture
Figure 5. Profiling & Purification Picture
Figure 6. Detection Picture
Figure 7. Functional Studies Picture
Figure 8. MicroRNA (miRNA) Revenue Market Share by Application in 2019
Figure 9. Cancer Picture
Figure 10. Infectious Diseases Picture
Figure 11. Immunological Disorder Picture
Figure 12. Cardiovascular Disease Picture
Figure 13. Neurological Disease Picture
Figure 14. Others Picture
Figure 15. Global MicroRNA (miRNA) Revenue (USD Million) and Growth Rate (2015-2025)
Figure 16. North America MicroRNA (miRNA) Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Europe MicroRNA (miRNA) Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Asia-Pacific MicroRNA (miRNA) Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. South America MicroRNA (miRNA) Revenue (Million USD) and Growth Rate (2015-2025)
Figure 20. Middle East and Africa MicroRNA (miRNA) Revenue (Million USD) and Growth Rate (2015-2025)
Figure 21. Global MicroRNA (miRNA) Revenue (Million USD) and Growth Rate (2015-2025)
Figure 22. Global MicroRNA (miRNA) Revenue Share by Players in 2019
Figure 23. Global Top 5 Players MicroRNA (miRNA) Revenue Market Share in 2019
Figure 24. Global Top 10 Players MicroRNA (miRNA) Revenue Market Share in 2019
Figure 25. Key Players Market Share Trend
Figure 26. Global MicroRNA (miRNA) Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 27. Global MicroRNA (miRNA) Revenue Market Share by Regions (2015-2020)
Figure 28. Global MicroRNA (miRNA) Revenue Market Share by Regions in 2018
Figure 29. North America MicroRNA (miRNA) Revenue and Growth Rate (2015-2020)
Figure 30. Europe MicroRNA (miRNA) Revenue and Growth Rate (2015-2020)
Figure 31. Asia-Pacific MicroRNA (miRNA) Revenue and Growth Rate (2015-2020)
Figure 32. South America MicroRNA (miRNA) Revenue and Growth Rate (2015-2020)
Figure 33. Middle East and Africa MicroRNA (miRNA) Revenue and Growth Rate (2015-2020)
Figure 34. North America MicroRNA (miRNA) Revenue Market Share by Countries (2015-2020)
Figure 35. North America MicroRNA (miRNA) Revenue Market Share by Countries in 2019
Figure 36. USA MicroRNA (miRNA) Revenue and Growth Rate (2015-2020)
Figure 37. Canada MicroRNA (miRNA) Revenue and Growth Rate (2015-2020)
Figure 38. Mexico MicroRNA (miRNA) Revenue and Growth Rate (2015-2020)
Figure 39. Europe MicroRNA (miRNA) Revenue Market Share by Countries (2015-2020)
Figure 40. Europe MicroRNA (miRNA) Revenue Market Share by Countries in 2019
Figure 41. Germany MicroRNA (miRNA) Revenue and Growth Rate (2015-2020)
Figure 42. UK MicroRNA (miRNA) Revenue and Growth Rate (2015-2020)
Figure 43. France MicroRNA (miRNA) Revenue and Growth Rate (2015-2020)
Figure 44. Russia MicroRNA (miRNA) Revenue and Growth Rate (2015-2020)
Figure 45. Italy MicroRNA (miRNA) Revenue and Growth Rate (2015-2020)
Figure 46. Asia-Pacific MicroRNA (miRNA) Revenue Market Share by Countries (2015-2020)
Figure 47. Asia-Pacific MicroRNA (miRNA) Revenue Market Share by Countries in 2019
Figure 48. China MicroRNA (miRNA) Revenue and Growth Rate (2015-2020)
Figure 49. Japan MicroRNA (miRNA) Revenue and Growth Rate (2015-2020)
Figure 50. Korea MicroRNA (miRNA) Revenue and Growth Rate (2015-2020)
Figure 51. India MicroRNA (miRNA) Revenue and Growth Rate (2015-2020)
Figure 52. Southeast Asia MicroRNA (miRNA) Revenue and Growth Rate (2015-2020)
Figure 53. South America MicroRNA (miRNA) Revenue Market Share by Countries (2015-2020)
Figure 54. South America MicroRNA (miRNA) Revenue Market Share by Countries in 2019
Figure 55. Brazil MicroRNA (miRNA) Revenue and Growth Rate (2015-2020)
Figure 56. Argentina MicroRNA (miRNA) Revenue and Growth Rate (2015-2020)
Figure 57. Middle East and Africa MicroRNA (miRNA) Revenue Market Share by Countries (2015-2020)
Figure 58. Middle East and Africa MicroRNA (miRNA) Revenue Market Share by Countries in 2019
Figure 59. Saudi Arabia MicroRNA (miRNA) Revenue and Growth Rate (2015-2020)
Figure 60. UAE MicroRNA (miRNA) Revenue and Growth Rate (2015-2020)
Figure 61. Egypt MicroRNA (miRNA) Revenue and Growth Rate (2015-2020)
Figure 62. South Africa MicroRNA (miRNA) Revenue and Growth Rate (2015-2020)
Figure 63. Global MicroRNA (miRNA) Revenue Share by Type (2015-2020)
Figure 64. Global MicroRNA (miRNA) Revenue Share by Type in 2019
Figure 65. Global MicroRNA (miRNA) Market Share Forecast by Type (2021-2025)
Figure 66. Global Sample collection Revenue Growth Rate (2015-2020)
Figure 67. Global miRNA cDNA Synthesis Revenue Growth Rate (2015-2020)
Figure 68. Global Profiling & Purification Revenue Growth Rate (2015-2020)
Figure 69. Global Detection Revenue Growth Rate (2015-2020)
Figure 70. Global Functional Studies Revenue Growth Rate (2015-2020)
Figure 71. Global MicroRNA (miRNA) Revenue Share by Application (2015-2020)
Figure 72. Global MicroRNA (miRNA) Revenue Share by Application in 2019
Figure 73. Global MicroRNA (miRNA) Market Share Forecast by Application (2021-2025)
Figure 74. Global Cancer Revenue Growth Rate (2015-2020)
Figure 75. Global Infectious Diseases Revenue Growth Rate (2015-2020)
Figure 76. Global Immunological Disorder Revenue Growth Rate (2015-2020)
Figure 77. Global Cardiovascular Disease Revenue Growth Rate (2015-2020)
Figure 78. Global Neurological Disease Revenue Growth Rate (2015-2020)
Figure 79. Global Others Revenue Growth Rate (2015-2020)
Figure 80. Global MicroRNA (miRNA) Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 81. Global MicroRNA (miRNA) Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 82. Global MicroRNA (miRNA) Revenue Market Share Forecast by Regions (2021-2025)
Figure 83. North America MicroRNA (miRNA) Revenue Market Forecast (2021-2025)
Figure 84. Europe MicroRNA (miRNA) Revenue Market Forecast (2021-2025)
Figure 85. Asia-Pacific MicroRNA (miRNA) Revenue Market Forecast (2021-2025)
Figure 86. South America MicroRNA (miRNA) Revenue Market Forecast (2021-2025)
Figure 87. Middle East and Africa MicroRNA (miRNA) Revenue Market Forecast (2021-2025)
Figure 88. Sales Channel: Direct Channel vs Indirect Channel

---